Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Epigenetics
Signal Transduction
Stem Cells
Signaling Pathways
Product Type
All Products
New Products
Small Molecules
Peptides
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular System
Endocrinology
Immunology
Neuroscience
Pain & Inflammation
Respiratory System
Other Cannabinoids
Inhibitors |
|
Cat.No. |
Product Name / Activity |
| 1462 | AACOCF3 |
| FAAH inhibitor | |
| 3381 | AM 1172 |
| FAAH inhibitor. Also anandamide uptake inhibitor and CB receptor partial agonist | |
| 3262 | JNJ 1661010 |
| Selective, reversible FAAH inhibitor | |
| 2452 | LY 2183240 |
| FAAH inhibitor. Also inhibits anandamide uptake | |
| 1421 | MAFP |
| Potent, irreversible FAAH inhibitor | |
| 1815 | Palmitoylisopropylamide |
| Inhibitor of FAAH | |
| 4175 | PF 3845 |
| Selective FAAH inhibitor | |
| 3307 | PF 750 |
| Selective FAAH inhibitor | |
| 4752 |
SA 57
|
| Potent FAAH inhibitor | |
| 4355 | TC-F 2 |
| Potent, reversible and selective FAAH inhibitor | |
| 3252 | WWL 70 |
| Potent ABHD6 inhibitor | |
Other |
|
Cat.No. |
Product Name / Activity |
| 2836 | Arachidonyl serotonin |
| Dual FAAH inhibitor/TRPV1 antagonist | |
| 1814 | N-ArachidonylGABA |
| Inhibits pain in vivo | |
| 1445 | N-Arachidonylglycine |
| Novel endocannabinoid. Suppresses pain in vivo | |
| 2288 | O-1918 |
| Silent antagonist for putative abnormal-CBD (Cat. No. 1297) receptor | |
| 0879 | Palmitoylethanolamide |
| FAAH and PAA substrate. Selective GPR55 agonist | |
| 2206 | 2-Palmitoylglycerol |
| Endogenous lipid; enhances activity of 2-arachidonylglycerol (Cat. No. 1298) | |
| 1684 | Tocrisolve™ 100 |
| Water-soluble emulsion; negative control for reagents in TocrisolveTM 100 | |






